Form 8-K - Current report:
SEC Accession No. 0001104659-26-074660
Filing Date
2026-06-16
Accepted
2026-06-16 17:00:09
Documents
11
Period of Report
2026-06-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K elut-20260611x8k.htm   iXBRL 8-K 80795
  Complete submission text file 0001104659-26-074660.txt   191534

Data Files

Seq Description Document Type Size
2 EX-101.SCH elut-20260611.xsd EX-101.SCH 2673
3 EX-101.LAB elut-20260611_lab.xml EX-101.LAB 15263
4 EX-101.PRE elut-20260611_pre.xml EX-101.PRE 9655
14 EXTRACTED XBRL INSTANCE DOCUMENT elut-20260611x8k_htm.xml XML 4670
Mailing Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904
Business Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904 240-247-1143
ELUTIA INC. (Filer) CIK: 0001708527 (see all company filings)

EIN.: 474790334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39577 | Film No.: 261095572
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)